Skip to main content
. 2016 Jun 1;7(28):43997–44012. doi: 10.18632/oncotarget.9766

Figure 1. A. BET inhibitors used in the study (+)-JQ1 and (PNZ5) as well as lead compound S1.

Figure 1

B. Growth inhibition curves of three gastric cancer cell lines derived from Brazilian patients after treatment with BET inhibitors (+)-JQ1 and PNZ5 for 72h.